Analysing GLP-1 Peptides with Strategic Precision

The analytical separation of therapeutic peptides presents significant chromatographic challenges due to their structural complexity, limited solubility, and the presence of closely related impurities with similar physicochemical properties. Peptides frequently exhibit strong secondary interactions, susceptibility to adsorption on metal surfaces, and a tendency to aggregate or precipitate, all of which demand carefully optimized chromatographic conditions. This seminar outlines practical strategies for peptide analysis with a focus on reversed-phase liquid chromatography (RP-LC), the most widely applied separation mode for peptide characterization and purity assessment.

Using tirzepatide – a structurally complex GLP-1 and GIP receptor agonist comprising 39 amino acids and a fatty acid side chain – as a case study, a systematic three-step analytical method development approach is demonstrated. Key parameters such as mobile phase composition, gradient slope, pH, temperature, pore size, and stationary phase chemistry are evaluated to achieve high-resolution separation of the target peptide from its impurities. Particular emphasis is placed on the influence of peptide solubility and temperature on chromatographic performance, as well as on the benefits of shallow gradients and optimized flow rates.

Furthermore, the role of bioinert column hardware is highlighted for sensitive peptides prone to metal-induced adsorption or oxidation, which can result in poor peak shapes, reduced recovery, and compromised quantitative reliability. Advanced hybrid stationary phases and bioinert coated hardware are shown to significantly improve peak symmetry, sensitivity, and robustness.

Overall, this seminar demonstrates that strategic method development combined with appropriate column chemistry and inert system components is essential for reliable, high-resolution peptide analysis in modern (U)HPLC workflows.